PULSE BIOSCIENCES, INC. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Paul A. LaViolette (CEO) and Jon Skinner (CFO) certified on August 6, 2026 that the Q2 2026 10-Q filing for the quarter ended June 30, 2026 contains no material misstatements, that financial statements fairly present the company's condition, and that disclosure controls and internal financial reporting controls are effective. Both officers confirmed no material weaknesses or fraud involving management in internal controls.
Why this rating
Standard SOX 302/906 certifications required quarterly; routine administrative compliance document with no new operational, financial, or strategic information disclosed.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.